Biomarin Pharmaceutical Inc financial data

Symbol
BMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
105 Digital Drive, Novato, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - Apr 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 294 % -40.8%
Quick Ratio 106 % -33.6%
Debt-to-equity 37.2 % -0.93%
Return On Equity 4.17 % +167%
Return On Assets 3.04 % +167%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 190 M shares +1.16%
Common Stock, Shares, Outstanding 190 M shares +1.16%
Entity Public Float 10.1 B USD +12.2%
Common Stock, Value, Issued 190 K USD +1.06%
Weighted Average Number of Shares Outstanding, Basic 189 M shares +1.18%
Weighted Average Number of Shares Outstanding, Diluted 199 M shares +2.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.47 B USD +13.7%
Cost of Revenue 505 M USD +0.48%
Research and Development Expense 780 M USD +18.1%
Costs and Expenses 2.29 B USD +9.01%
Operating Income (Loss) 184 M USD +147%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 237 M USD +229%
Income Tax Expense (Benefit) 31.9 M USD +5907%
Net Income (Loss) Attributable to Parent 205 M USD +187%
Earnings Per Share, Basic 1.09 USD/shares +195%
Earnings Per Share, Diluted 1.06 USD/shares +172%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 747 M USD +28.8%
Accounts Receivable, after Allowance for Credit Loss, Current 637 M USD +6.57%
Inventory, Net 1.14 B USD +23.8%
Other Assets, Current 163 M USD -5.71%
Assets, Current 2.99 B USD +5.03%
Deferred Income Tax Assets, Net 1.55 B USD +2.35%
Property, Plant and Equipment, Net 1.06 B USD -0.72%
Operating Lease, Right-of-Use Asset 42.7 M USD +22.3%
Intangible Assets, Net (Excluding Goodwill) 280 M USD -14.2%
Goodwill 196 M USD 0%
Other Assets, Noncurrent 185 M USD +23.1%
Assets 6.87 B USD +6.82%
Employee-related Liabilities, Current 148 M USD +10.5%
Contract with Customer, Liability, Current 5.15 M USD
Liabilities, Current 1.09 B USD +81.9%
Operating Lease, Liability, Noncurrent 38 M USD +44.5%
Other Liabilities, Noncurrent 117 M USD +27%
Liabilities 1.8 B USD +1.36%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.05 M USD +90.2%
Retained Earnings (Accumulated Deficit) -533 M USD +27.8%
Stockholders' Equity Attributable to Parent 5.07 B USD +8.9%
Liabilities and Equity 6.87 B USD +6.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 47 M USD
Net Cash Provided by (Used in) Financing Activities -42.8 M USD -5.03%
Net Cash Provided by (Used in) Investing Activities -14.2 M USD +52.6%
Common Stock, Shares Authorized 500 M shares 0%
Common Stock, Shares, Issued 190 M shares +1.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.13 M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 747 M USD +28.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42 M USD -1.18%
Deferred Tax Assets, Valuation Allowance 119 M USD +2.52%
Operating Lease, Liability 46.7 M USD +35.7%
Depreciation 42.6 M USD +14.5%
Payments to Acquire Property, Plant, and Equipment 26.1 M USD +6.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 215 M USD +248%
Lessee, Operating Lease, Liability, to be Paid 58.4 M USD +46.9%
Property, Plant and Equipment, Gross 1.95 B USD +3.91%
Operating Lease, Liability, Current 8.64 M USD +6.83%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.86 M USD +30%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.2 M USD +15.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +19.6%
Deferred Income Tax Expense (Benefit) 285 K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.7 M USD +119%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.97 M USD +33.7%
Deferred Tax Assets, Operating Loss Carryforwards 19 M USD -7.9%
Deferred Federal Income Tax Expense (Benefit) -70.8 M USD +10.7%
Current Income Tax Expense (Benefit) 65.9 M USD +9.65%
Unrecognized Tax Benefits 277 M USD +19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.06 M USD +41.9%
Operating Lease, Payments 9.98 M USD -7.25%
Current State and Local Tax Expense (Benefit) 5.1 M USD +0.79%
Current Federal Tax Expense (Benefit) 25.1 M USD +96.3%
Amortization of Intangible Assets 14.3 M USD -8.76%
Depreciation, Depletion and Amortization 27.4 M USD +3.52%
Deferred Tax Assets, Net of Valuation Allowance 1.62 B USD +2.77%
Share-based Payment Arrangement, Expense 212 M USD +4.69%
Deferred State and Local Income Tax Expense (Benefit) -8.03 M USD -56.1%
Interest Expense 17.2 M USD +8.27%